Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Arjuna's Low-dose Ashwagandha Helps Ease Stress and Anxiety


News provided by

Arjuna Natural Ltd.

Nov 26, 2024, 07:00 ET

Share this article

Share toX

Share this article

Share toX

New clinical study reveals Shoden® Ashwagandha can help reduce cortisol levels and lower stress

KERALA, India, Nov. 26, 2024 /PRNewswire/ -- Nutraceutical innovators Arjuna Natural, Pvt. Ltd., announce the publication of a new clinical study that highlights the positive effect of its proprietary Shoden® brand ashwagandha extract in alleviating stress and anxiety. More importantly, the extract exhibited efficacy even at low doses.

Continue Reading
Arjuna’s Low-dose Ashwagandha Helps Ease Stress and Anxiety
Arjuna’s Low-dose Ashwagandha Helps Ease Stress and Anxiety

As people around the world become increasingly stressed out and anxious in this post-Covid era, they are seeking natural—yet effective—science-backed means to unwind. The Indian adaptogenic, Withania somnifera, known as ashwagandha, has a time-honored reputation for its role in easing stress and enhancing sleep quality. Today's science-based investigations are supporting the ancient botanical intervention.

Until today, this celebrated botanical has presented absorption challenges due to the low solubility of certain active compounds, particularly withanolides. Withanolides are the primary phytochemical family present in the plant and have proven antioxidant, anti-inflammatory, and stress-calming properties.

The study
Published in the peer-reviewed journal Heliyon in September 2024, the randomized, double-blind, placebo-controlled study enrolled 60 healthy adults complaining of higher-than-normal levels of stress and anxiety. Led by Deo Nidhi Mishra, the study was conducted at Nirmal Hospital, Jhansi, India and tested out Shoden on alleviating stress and anxiety at low daily dose of 60mg and 120mg. Shoden is Arjuna's advanced formulation of ashwagandha extract standardised to 35% withanolide glycosides.

Following 60 days of supplementation, the volunteers in the Shoden groups showed significantly reduced levels of anxiety, (59%) compared to the placebo group, as measured by the Hamilton Anxiety Rating Scale (HAMA). Morning blood cortisol levels, the hormone involved in stress response, was lowered by 66% and 67% among the Shoden group. The placebo group only exhibited a 2.2% change in cortisol. Testosterone levels also increased significantly in men using Shoden.

The study participants also reported a marked reduction in stress levels, as per the Perceived Stress Scale (PSS), along with significant improvements in the Clinical Global Impressions (CGI). The CGI assessment provides a clinician's view of the subject's overall functioning before and after the intervention and the Patient's Global Impression of Change (PGIC) scales.

Jump ahead
"This study represents a significant advancement in our understanding of the profound effects that low-dose Shoden Ashwagandha can have in managing stress and anxiety," asserts Benny Antony, PhD, Joint Managing Director of Arjuna Natural. "That these benefits were achieved at such a low dose underscores the exceptional work done by our research team in offering an optimal solution for formulators seeking science-backed stress-relief products."

The new research builds on the promising results from an earlier clinical trial involving a 240mg dose of Shoden and demonstrates Shoden to be as effective on even a quarter of that dose. Earlier research indicates identified withanolide glycosides as contributors of the positive effect on stress, lowering cortisol levels through modulation of the hypothalamic-pituitary-adrenal (HPA) axis and counteracting some of the negative impacts of cortisol.

"Prolonged exposure to high levels of cortisol is known to exert detrimental effects on mental and physical wellbeing," explains Antony. "It leads to increased feelings of anxiety which over long periods of time will decrease the quality of life. Withanolides can increase the activity of certain neurotransmitters, or 'happy' hormones, such as serotonin, acetylcholine, and GABA all of which can help regulate the HPA axis, keeping cortisol in check and reducing stress."

Safe, sustainable
Shoden is manufactured from carefully selected and validated ashwagandha roots and leaves, to ensure zero waste and maximum economic value for its partnering farmers. It is a highly purified extract standardized to more than 35% glycowithanolides.

"We have conducted extensive safety studies on Shoden. This includes acute and subchronic toxicity studies on animals, which have demonstrated excellent safety profiles", continues Antony. "We are currently conducting human clinical trials to further establish the long-term safety of Shoden, which continues to demonstrate an efficacy without compromising safety." Shoden enjoys the backing of 11 studies and 23 patents granted for its unique formulation and manufacturing methods.

Arjuna stresses that it actively engages with farmers, providing training on Good Agricultural Practices (GAP) for sustainable and responsible cultivation practices that maintain the health of the soil and ecosystem while also securing high-quality ingredients for its formulations. This collaboration also strengthens its community of farmers who rely on their business relationship with the company.

About Arjuna Natural Pvt, Ltd.

For more than a quarter of a century, Arjuna Natural has been India's leading manufacturer of standardized spice and botanical extracts for food supplement industries, dedicated to ecofriendly and sustainable practices. Established in 1989, the company has grown rapidly, with customers in 70 countries, and has an advanced research facility that works in collaboration with international universities on phytochemistry, pharmacokinetics, formulation, development, pre-clinical and toxicity studies. Arjuna Natural's facilities comply with the highest world standards, are GMP-certified, and have ISO, NSF, halal and Star-K kosher certification.

For further information, please contact:

Company contact                                                                        Press Contact
Arjuna Natural Pvt                                                                         NutriPR
Benny Antony, PhD                                                                       Liat Simha
Joint Managing Director                                                                Tel: +972-9-9742893
Email: [email protected]                                                  E-mail: [email protected]
Website: www.arjunanatural.com                                                  Website: www.nutripr.com
Twitter: @ArjunaExtracts   

Photo: https://mma.prnewswire.com/media/2567583/Arjuna_Ashwagandha.jpg

SOURCE Arjuna Natural Ltd.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Enhanced Bioavailability in Shoden® Ashwagandha Linked to Withanolide Glycosides

Enhanced Bioavailability in Shoden® Ashwagandha Linked to Withanolide Glycosides

A new clinical study identified withanolide glycosides as the key drivers of superior bioavailability in ashwagandha (Withania somnifera) extracts....

Somin-On™ Ashwagandha Improves Memory in Adults with Mild Cognitive Impairment

Somin-On™ Ashwagandha Improves Memory in Adults with Mild Cognitive Impairment

A new clinical study of Somin-On™, an ashwagandha (Withania somnifera) withanolide extract standardized to Sominone, highlights its potential for...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Food & Beverages

Food & Beverages

Medical Pharmaceuticals

Medical Pharmaceuticals

Mental Health

Mental Health

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.